COO Vikas Mehta sold 154.3K shares of ACVA at $19.19; holds 432.5K post-transaction with consistent prior sell timing
Mehta sold 154,324 shares at $19.19, reducing his holdings by 26.3%, with current price at $19.94 near the 52-week high. His track record across all tickers shows a 90d well-timed rate of 85.71%, and his prior three measurable ACVA sales all achieved negative 90-day returns (-4.2%, -2.3%, -2.6%), indicating consistent timing accuracy at this ticker. However, this transaction occurs while the stock is at its 52-week peak and has risen 12.7% over 90 days, creating a near-term price risk for the transaction outcome. The company posted $160.6M in latest-quarter revenue with 14.2% annual growth but remained unprofitable with -$17.1M net income, leaving fundamental support uncertain as the stock trades at strength.
COO Vikas Mehta sold 154,323 shares of ACVA for $2.9M (blended avg $18.74); retains 467,090 shares post-sale.
COO Vikas Mehta executed 2 separate sales totaling 154,323 shares for $2,891,580.83, reducing his holdings by 24.8% from pre-transaction levels. His prior 5 sales at ACVA were all well-timed at the 90-day mark with negative returns ranging from -1.4% to -6.1%, and his cross-ticker track record shows a 85.71% well-timed sell rate with an average 90-day return of -2.7%. The sale occurs while the stock trades 3.9% below its 52-week high of $19.32 and after a +5.4% gain over the prior 30 days, but the company remains unprofitable (net income of $-17.1M in the most recent fiscal year despite 14.2% annual revenue growth). The consistent pattern of well-timed prior exits at this ticker, combined with current fundamental underperformance despite revenue growth, warrants monitoring of this insider's predictive signal for near-term stock performance.
